Apple cider vinegar,
does it really help with Improvement of postprandial glucose, HbA1c, and body weight?
research showsA meta-analysis reported signals of FPG -7.97 mg/dL and HbA1c -0.50%, but these are surrogate markers and heterogeneity was high. Kondo 2009 described the intervention only as 'vinegar,' so it does not establish an apple-cider-vinegar-specific effect. A paper reporting a large weight effect was retracted after its analyses could not be reproduced and is excluded from confirmatory evidence.
ads claimGummies, tablets, and liquids may be described as blocking glucose spikes and reducing weight together. Whether gummies or tablets provide the same acetic-acid exposure as liquid-vinegar trials varies by product.
Useful facts when choosing a product
- Liquid trials commonly used 15-30 mL/day.
- Main outcomes were surrogate markers such as postprandial glucose, FPG, and HbA1c.
- Acidic liquids may erode teeth or irritate the esophagus.
- Delayed gastric emptying may be relevant in gastroparesis.
Chamgap Semantic Classification Code
Candidate index · review held
UNK.apple-cider-vinegar.UNK.postprandial-glucose-hba1c-and-body-weight.improve.placeboUnknown > Apple cider vinegar > Unknown > postprandial glucose, HbA1c, and body weight > Improvement claim > Placebo
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
The Hadi 2021 meta-analysis reported FPG -7.97 mg/dL and HbA1c -0.50% across nine studies, but the outcomes were surrogate markers and heterogeneity was high. Kondo 2009 reported a small weight reduction with 15-30 mL/day of 'vinegar' in 175 participants, and the authors were employed by Mizkan. Because the vinegar type was not identified as apple cider vinegar, the result does not establish an ACV-specific effect. A 2024 paper reporting a large weight effect was retracted in 2025 after its analyses could not be reproduced and data concerns remained; it is excluded from confirmatory evidence.
Why this is classified as C (47)
FPG and HbA1c signals are surrogate and highly heterogeneous. Kondo 2009 studied unspecified vinegar, so its result cannot be attributed specifically to apple cider vinegar, and the large-effect weight paper was retracted and excluded. Together these limitations support C with 47 points.
Counterpoint. Small short-term glycemic and weight changes remain possible. The large weight-loss values from the retracted paper were excluded.
Rejudgment record. New judgment — FPG and HbA1c signals are surrogate and highly heterogeneous; unspecified-vinegar results cannot be attributed specifically to apple cider vinegar, and the large-effect weight paper was retracted, supporting C with 47 points.
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Postprandial-glucose improvement | C | Repeated in small acute trials, but it is a surrogate marker. |
| HbA1c improvement | C | Meta-analyses were positive, but heterogeneity was 91-99%. |
| Body-weight improvement | C | Kondo 2009 reported only 'vinegar,' not an ACV-specific intervention, and the large-effect paper was retracted after its analyses could not be reproduced. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Hadi A et al. 2021 | Systematic review and meta-analysis of RCTs | 10 | Unknown | FPG and HbA1c | FPG -7.97 mg/dL and HbA1c -0.50%, with high heterogeneity. | Key |
| Kondo T et al. 2009 | Double-blind placebo-controlled trial | 175 | Mizkan Group | Body weight, fat mass, and TG | About 1-2 kg of weight reduction was reported at 12 weeks, but the intervention was identified only as 'vinegar' and cannot be attributed specifically to ACV. | Supportive |
| BMJ Group 2025 | Retraction notice | 120 | Not applicable | Reliability of a weight trial | Retracted because analyses could not be reproduced and data concerns remained. | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Final verification and publication gate: Codex · Evidence date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Apple cider vinegar x Improvement of postprandial glucose, HbA1c, and body weight — Evidence Grade C·47. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/apple-cider-vinegar-glucose-hba1c-weight/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.